Showing results (831-840 of 1,376) with videos related to
Sort By:
Pageof 138
Drug Development Research|August 15, 2017
On BH3 Mimetics and Ca2+ SignalingPawel E Ferdek, Monika A JakubowskaDrug Development Research|May 13, 2016
Isobolographic Analysis of the Interaction Between Tapentadol and Ketorolac in a Mouse Model of Visceral PainJuan R Zapata-Morales, Othoniel H Aragon-Martinez, Tely Adriana Soto-Castro, et al.Drug Development Research|June 15, 2016
The Antinociceptive Effects of Tramadol and/or Gabapentin on Rat Neuropathic Pain Induced by a Chronic Constriction InjuryJanette Nallely Corona-Ramos, Minarda De la O-Arciniega, Myrna Déciga-Campos, et al.Drug Development Research|May 17, 2016
Pyran Template Approach to the Design of Novel A3 Adenosine Receptor AntagonistsAn-Hu Li, Xiao-Duo Ji, Hak Sung Kim, et al.Drug Development Research|June 1, 2016
Antinociceptive Effect of Racemic Flurbiprofen and Caffeine Co-Administration in an Arthritic Gout-Type Pain in RatsRicardo Liévano-Reyes, Hermínia Ines Pérez-Méndez, Aida Solís-Oba, et al.Drug Development Research|June 1, 2016
The Effect of Experimental Thyroid Dysfunction on Markers of Oxidative Stress in Rat PancreasMojtaba Sajadian, Mohammad Hashemi, Saeedeh Salimi, et al.Drug Development Research|June 1, 2016
Topical Anti-Inflammatory and Analgesic Effects of Multiple Applications of S(+)-Flurbiprofen Plaster (SFPP) in a Rat Adjuvant-Induced Arthritis ModelMasanori Sugimoto, Yoshihisa Toda, Miyuki Hori, et al.Drug Development Research|September 19, 2017
Is 2-Hydroxypropyl-β-cyclodextrin a Suitable Carrier for Central Administration of Δ9 -Tetrahydrocannabinol? Preclinical EvidenceR Agabio, F Sanna, C Lobina, et al.Drug Development Research|September 24, 2017
Synergistic Interaction of a Gabapentin- Mangiferin Combination in Formalin-Induced Secondary Mechanical Allodynia and Hyperalgesia in Rats Is Mediated by Activation of NO-Cyclic GMP-ATP-Sensitive K+ Channel PathwayBeatriz Godínez-Chaparro, Geovanna Nallely Quiñonez-Bastidas, Isabel Rocío Rojas-Hernández, et al.Drug Development Research|November 24, 2020
Proteolysis targeting chimera (PROTAC) for epidermal growth factor receptor enhances anti-tumor immunity in non-small cell lung cancerKai Wang, Hongping ZhouPageof 138